The Minneapolis Heart Institute Foundation (MHIF) is presenting data on trends in ST-elevation myocardial infarction (STEMI) at the American College of Cardiology’s Annual Scientific Session (ACC.24). An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovascular disease.
April 06, 2024
Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks
April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in…
Read More
Smidt Heart Institute experts will be available for media interviews throughout ACC.24.
April 06, 2024
ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge
April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more…
Read More
Registration is open for a leading conference on structural heart disease announced by the Cardiovascular Research Foundation, CRF.
April 05, 2024
Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit
April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit…
Read More
Cardiawave SA will present the 30-day follow-up results for 60 patients enrolled in its European pivotal study to the 73rd annual conference of the American College of Cardiology in Atlanta, Georgia
April 05, 2024
Cardiawave is Presenting the 30-day Follow-up Results from its “Valvosoft Pivotal Study” on the Teatment of Severe Symptomatic Aortic Valve Stenosis at ACC24
April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused…
Read More
The acquisition enhances Johnson and Johnson’s ability to transform the treatment landscape for cardiovascular disease and continue to improve patient outcomes
April 05, 2024
Johnson and Johnson to Acquire Shockwave Medical
April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a…
Read More
Viz.ai will be announced new clinical data supporting advancements in cardiology care during the American College of Cardiology Scientific Sessions, ACC.24
April 04, 2024
Real-world Evidence at the American College of Cardiology Scientific Session ACC.24 to Demonstrate Positive Impact of Viz.ai on Suspected Disease Detection and Patient Triage for Improved Care
April 4, 2024 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced new…
Read More
Virtual Reality Simulation Company Collaborates with American College of Cardiology to Help Cardiovascular Clinicians Immersively Practice Clinical Procedures
April 04, 2024
Osso VR Expands Cardiology Training through ACC Collaboration
April 4, 2024 — Osso VR, a leader in immersive procedural training, announces the release of a co-developed curriculum…
Read More
Early coronary disease and impaired heart function, with increased coronary vessel wall thickness, in asymptomatic, middle-aged individuals living with HIV has been reported in a new study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).
April 04, 2024
New Study Finds Early Coronary Disease, Impaired Heart Function in Asymptomatic People with HIV
April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with…
Read More
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. 
April 04, 2024
FDA Announces Medos International SĂ rl Recall of Cerenovus CEREBASE DA Guide Sheath due to Cracking of the Distal Catheter Shaft
April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling…
Read More
Here is a look at the most-read content during the month of March on dicardiology.com
By Melinda Taschetta-Millane
April 04, 2024
Top 10: What Viewers Were Reading in March
Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health…
Read More
Large study adds to growing body of evidence that vaping may harm the heart
April 03, 2024
GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-quality Cardiac Images
April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid…
Read More
Large study adds to growing body of evidence that vaping may harm the heart
April 03, 2024
FDA Clears First AI to Aid Heart Failure Detection During Routine Check-ups
April 3, 2024 — - Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung…
Read More
In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization, the American College of Cardiology (ACC) has planned a full range of educational programming, special events and peer networking scheduled throughout the April 6-8 event in Atlanta, GA. 
Christine Book
April 03, 2024
American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24
April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the…
Read More
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death
April 03, 2024
FDA Announces Teleflex and Arrow International Recall of ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits for Increased Resistance That May Lead to Vessel Injuries, Narrowing, or Blockage
April 3, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex and Arrow International are…
Read More
Study shows women quickly catch up to men in terms of cardiovascular risk
April 02, 2024
Heart Health Declines Rapidly After Menopause
April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to…
Read More
Study finds patients on average consume more than twice the recommended daily amount of sodium with little variation across socioeconomic groups
April 02, 2024
Majority of People with Heart Disease Consume Too Much Sodium
April 2, 2024 — Individuals with heart disease stand to gain the most from a low sodium diet but, on average, consume…
Read More
Concept Medical has received FDA IDE Approval for a US Clinical Study of its MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter..
April 02, 2024
Concept Medical Receives FDA IDE Approval for US Clinical Study of MagicTouch AVF Indication
April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational…
Read More
Large study adds to growing body of evidence that vaping may harm the heart
April 02, 2024
Study Links E-Cigarette Use with Higher Risk of Heart Failure
April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those…
Read More
Abbott has announced U.S Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve.
April 02, 2024
Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip
April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its-…
Read More
Approvals based on positive CLEAR Outcomes data and reflect a highly differentiated product profile
April 01, 2024
U.S. FDA Approves Broad New Labels for NEXLETOL and NEXLIZET to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now